U.S. FDA approves bluebird bio’s gene therapy for a rare neurological disorder By Reuters
[ad_1] © Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020....